Glycerol phenylbutyrate reduces hepatic encephalopathy events

And ammonia levels compared to placebo

2014-02-25

(Press-News.org) Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.

Patients with hepatic encephalopathy experience neuropsychiatric symptoms that may range from mild confusion to coma. There is conflicting evidence on the link between elevated blood ammonia and hepatic encephalopathy. Poorly-absorbable disaccharides and antibiotics are currently used to treat encephalopathy and are generally believed to act by reducing ammonia production in the intestine.

"GPB is approved to treat urea cycle defects that prevent the removal of ammonia from the body," explains Dr. Bruce F. Scharschmidt, Sr. VP & Chief Medical Officer with Hyperion Therapeutics in San Francisco, CA. "Our trial was the first to investigate the efficacy of a direct ammonia lowering agent in patients with cirrhosis and hepatic encephalopathy."

This phase 2 clinical trial enrolled 178 cirrhosis patients, including 59 who were already taking rifaximin. Participants who had two or more hepatic encephalopathy events within the six months prior to the trial were included. The trial aim was to determine the proportion of patients with hepatic encephalopathy taking 6mL GBP twice daily compared to placebo.

Results show that the percentage of patients who experienced hepatic encephalopathy events was significantly reduced among patients randomized to GPB versus placebo at 21% vs. 36%, respectively. Total hepatic encephalopathy events were lower in patients taking the medication (35) versus placebo (57). Hospitalizations due to hepatic encephalopathy tended to be less frequent among patients taking GPB at 13 compared to those in the placebo group at 25.

The trial results also indicate that ammonia levels in the blood of patients on GPB were lower than subjects not taking the medication. "Our findings provide evidence that elevated blood ammonia plays an important role in the development of hepatic encephalopathy," concludes Dr. Scharschmidt. "GPB reduced the risk of hepatic encephalopathy in patients with cirrhosis and further investigation of its therapeutic potential for patients with hepatic encephalopathy is warranted."

In a related editorial published in Hepatology, Dr. Meritxell Ventura-Cots with the Hospital Vall Hebron in Barcelona, Spain writes, "The study by Rockey et al. shows that GPB improves the outcome among cirrhotic patients with highly recurrent hepatic encephalopathy. The new drug avoids the risk of sodium overload, was well tolerated and had a good safety profile."

INFORMATION: This study and editorial are published in Hepatology. Media wishing to receive a PDF of the articles may contact sciencenewsroom@wiley.com.

Full citations: "Randomized, Double-Blind, Controlled Study of Glycerol Phenylbutyrate in Hepatic Encephalopathy." Don C. Rockey, John M.Vierling, Parvez Mantry, Marwan Ghabril, Robert S. Brown Jr., Olga Alexeeva, Igor A. Zupanets, Vladimir Grinevich, Andrey Baranovsky, Larysa Dudar, Galyna Fadieienko, Nataliya Kharchenko, Iryna Klaryts'ka, Vyacheslav Morozov, Priya Grewal, Timothy McCashland, K. Gautham Reddy, K. Rajender Reddy, Vasyl Syplyviy, Nathan M. Bass, Klara Dickinson, Catherine Norris, Dion Coakley, Masoud Mokhtarani and Bruce F. Scharschmidt for the HALT-HE Study Group.Hepatology; (DOI: 10.1002/hep.26611) Print Issue Date: March, 2014.

URL: http://doi.wiley.com/10.1002/hep.26611 Editorial: "Drug-Induced Removal of Nitrogen Derivatives in Urine: A New Concept Whose Time Has Come." Juan Cordoba and Meritxell Ventura-Cots. Hepatology; (DOI: 10.1002/hep.26789) Print Issue Date: March, 2014.

URL: http://doi.wiley.com/10.1002/hep.26789

Author Contact: Media wishing to speak with Dr. Scharschmidt may contact Sylvia Wheeler with Hyperion Therapeutics at Sylvia.Wheeler@hyperiontx.com.

About the Journal Hepatology is the premier publication in the field of liver disease, publishing original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Hepatology is published on is published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD). For more information, please visit http://wileyonlinelibrary.com/journal/hep.

About Wiley Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.

ELSE PRESS RELEASES FROM THIS DATE:

Sensor-based irrigation systems show potential to increase greenhouse profitability

2014-02-25

COLLEGE PARK, MD--Wireless sensor-based irrigation systems can offer significant benefits to greenhouse operators. Advances in sensor technology and increased understanding of plant physiology have made it possible for greenhouse growers to use water content sensors to accurately determine irrigation timing and application rates in soilless substrates. The wireless sensor systems provide more accurate measurements of substrate moisture than qualitative methods, and can save irrigation water, labor, energy, and fertilizer. The authors of a report published in HortTechnology ...

Technique to create holes in graphene could improve water filters, desalination

2014-02-25

Researchers have devised a way of making tiny holes of controllable size in sheets of graphene, a development that could lead to ultrathin filters for improved desalination or water purification. The team of researchers at MIT, Oak Ridge National Laboratory, and in Saudi Arabia succeeded in creating subnanoscale pores in a sheet of the one-atom-thick material, which is one of the strongest materials known. Their findings are published in the journal Nano Letters. The concept of using graphene, perforated by nanoscale pores, as a filter in desalination has been proposed ...

Report details multiple commercial uses of wireless sensor networks

2014-02-25

ATHENS, GA--Managing the quality and quantity of freshwater resources is one of the most serious environmental challenges of the 21st century. Global population growth and increasing urbanization have resulted in increased competition for water resources among domestic, industrial, and agricultural users. Challenged to find ways to manage irrigation needs while recognizing the limitations of freshwater resources, many commercial horticulture operations are showing increased interest in the use of wireless sensor networks (WSN)--technology designed to both monitor and control ...

Analysis: 32 years of US filicide arrests

2014-02-25

PROVIDENCE, R.I. [Brown University] — Instances in which parents kill their children may seem so horrifying and tragic that they defy explanation. Published scientific and medical research, meanwhile, doesn't offer much epidemiological context to help people understand patterns among such heinous crimes. A paper in the March edition of the journal Forensic Science International provides the first comprehensive statistical analysis of filicide in the United States, drawing on 32 years of data on more than 94,000 arrests. The study also explores possible underlying psychiatric ...

CWRU researchers find byproducts of bacteria-causing gum disease incite oral cancer growth

2014-02-25

Researchers from Case Western Reserve University have discovered how byproducts in the form of small fatty acids from two bacteria prevalent in gum disease incite the growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth. The discovery could lead to early saliva testing for the bacteria, which, if found, could be treated and monitored for signs of cancer and before it develops into a malignancy, researchers say. "These new findings provide one of the first looks at how the periodontal bacteria create a unique microenvironment in the oral cavity ...

Eliminating maternal mortality could extend life expectancy in reproductive ages

2014-02-25

Maternal death rates represent the single largest health discrepancy between developed and developing populations, with nearly all - over 99% -- maternal deaths worldwide occurring in developing countries and over half of them in sub-Saharan Africa countries. Eliminating maternal mortality, which is defined as the deaths related to pregnancy, would result in a gain of over a half year (0.6 years) in life expectancy worldwide, according to a new study by researchers at Johns Hopkins Bloomberg School of Public Health. The study is published February 13 in PLOS ONE. Over ...

Magnetic medicine

2014-02-25

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. The experiments, described on the website of ACS Nano on February 24, represent a significant step toward using nanoparticles and magnetism to treat a variety of conditions, the researchers say. "Size was key to this experiment," says Jonathan Schneck, M.D., Ph.D., a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine's Institute for Cell Engineering. ...

3-D printer creates transformative device for heart treatment

2014-02-25

Igor Efimov, PhD, at the School of Engineering & Applied Science at Washington University in St. Louis and an international team of biomedical engineers and materials scientists have created a 3-D elastic membrane made of a soft, flexible, silicon material that is precisely shaped to match the heart's epicardium, or the outer layer of the wall of the heart. Current technology is two-dimensional and cannot cover the full surface of the epicardium or maintain reliable contact for continual use without sutures or adhesives. The team can then print tiny sensors onto the membrane ...

Vitamin A may help boost immune system to fight tuberculosis

2014-02-25

Tuberculosis is a major global problem, affecting 2 billion people worldwide and causing an estimated 2 million deaths annually. Western countries are once again tackling the disease, with recent outbreaks in Los Angeles and London. The rise of drug-resistant TB, called a "ticking time bomb" by the World Health Organization, and the high cost of fighting the disease highlight the need for new approaches to treatment. In findings published in the March 1 issue of the Journal of Immunology, UCLA researchers investigating the role of nutrients in helping the immune ...

Discovery of a 'conductor' in muscle development

2014-02-25

Montréal, February 25, 2014 – A team led by Jean-François Côté, researcher at the IRCM, identified a ''conductor'' in the development of muscle tissue. The discovery, published online yesterday by the scientific journal Proceedings of the National Academy of Sciences (PNAS), could have an important impact on the treatment of muscular diseases such as myopathies and muscular dystrophies. "For several years, we have been studying myogenesis, a process by which muscles are formed during embryonic development," says Jean-François Côté, PhD, Director of the Cytoskeletal Organization ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

Glycerol phenylbutyrate reduces hepatic encephalopathy events

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: